|
GB690816A
(en)
|
1950-01-02 |
1953-04-29 |
British Drug Houses Ltd |
Improvements in or relating to the manufacture of substituted phenoxy acetic acids
|
|
US3278524A
(en)
*
|
1962-03-13 |
1966-10-11 |
Beecham Group Ltd |
Penicillins and their production
|
|
CH432119A
(de)
|
1963-02-22 |
1967-03-15 |
Geigy Ag J R |
Verwendung von Halogen-o-hydroxy-diphenyläthern als antimikrobielle Mittel
|
|
US3673243A
(en)
*
|
1968-05-08 |
1972-06-27 |
Sumitomo Chemical Co |
Novel process for producing o-anilinophenylaliphatic acid derivatives
|
|
BE754532A
(fr)
*
|
1969-08-07 |
1971-02-08 |
Rhone Poulenc Sa |
Nouveaux derives de la dibenzazepine et leur preparation
|
|
BE790679A
(fr)
|
1971-11-03 |
1973-04-27 |
Ici Ltd |
Derives de l'indole
|
|
DE2412520C2
(de)
*
|
1973-03-30 |
1982-09-16 |
F. Hoffmann-La Roche & Co. AG, 4002 Basel |
Tricyclische Verbindungen, Verfahren zu deren Herstellung und diese enthaltende Präparate
|
|
DD113545A5
(enExample)
*
|
1973-03-30 |
1975-06-12 |
|
|
|
US3954764A
(en)
*
|
1973-03-30 |
1976-05-04 |
Hoffmann-La Roche Inc. |
Dibenzo [b,f]thiepins bearing piperazinyl substitution
|
|
JPS5239888B2
(enExample)
*
|
1973-05-28 |
1977-10-07 |
|
|
|
CH582476A5
(enExample)
|
1973-10-29 |
1976-12-15 |
Ciba Geigy Ag |
|
|
ES431425A1
(es)
*
|
1973-10-29 |
1977-01-16 |
Eisai Co Ltd |
Un procedimiento para la preparacion de derivados del acido 2-(m-fenoxifenil)-propionico.
|
|
FI753625A7
(enExample)
*
|
1975-01-06 |
1976-07-07 |
Spofa Vereinigte Pharma Werke |
|
|
GB1585963A
(en)
|
1976-10-14 |
1981-03-11 |
Lilly Industries Ltd |
Aryl sulphur compounds
|
|
US4248618A
(en)
*
|
1977-05-06 |
1981-02-03 |
Ici Australia Limited |
Derivatives of (pyrimidyloxy)phenoxy-alkanecarboxylic acid and herbicidal compositions thereof
|
|
CS196893B1
(en)
*
|
1977-12-22 |
1980-04-30 |
Miroslav Protiva |
3-fluor-10-piperazino-8-substituted 10,11-dihydro-dibenzothiepines
|
|
FR2428629A1
(fr)
*
|
1978-06-14 |
1980-01-11 |
Hexachimie |
Nouveaux composes bis(aryloxycarboxyliques), leur preparation et leur utilisation en therapeutique
|
|
JPS5951943B2
(ja)
|
1978-08-21 |
1984-12-17 |
キツセイ薬品工業株式会社 |
新規なイミダゾ−ル誘導体
|
|
GB2041363B
(en)
|
1979-01-19 |
1982-10-06 |
Pfizer Ltd |
N-benzyl-imidazoles
|
|
US4670566A
(en)
*
|
1979-07-12 |
1987-06-02 |
A. H. Robins Company, Incorporated |
3-methyl-hio-4-(5-, 6-, or 7-)phenylindolindolin-2-ones
|
|
US4486593A
(en)
|
1983-01-19 |
1984-12-04 |
The Upjohn Company |
2-,3-, or 4-Pyridinylmethylamino arylic acids as thromboxane A2 synthetase and 5-lipoxygenase inhibitors
|
|
JPS62198616A
(ja)
*
|
1986-02-24 |
1987-09-02 |
Res Dev Corp Of Japan |
脳血流量改善・脳細胞保護剤
|
|
US5006542A
(en)
*
|
1988-10-31 |
1991-04-09 |
E. R. Squibb & Sons, Inc. |
Arylthioalkylphenyl carboxylic acids, derivatives thereof, compositions containing same and method of use
|
|
US5145790A
(en)
*
|
1990-05-04 |
1992-09-08 |
Abbott Laboratories |
Reagents and method for detecting polychlorinated biphenyls
|
|
JPH0429980A
(ja)
*
|
1990-05-25 |
1992-01-31 |
Hokko Chem Ind Co Ltd |
アリールプロピオン酸誘導体および除草剤
|
|
EP0540165A1
(en)
|
1991-10-03 |
1993-05-05 |
Zeneca Limited |
Alkanoic acid derivatives
|
|
US5827868A
(en)
*
|
1991-10-07 |
1998-10-27 |
E. R. Squibb & Sons, Inc. |
Prostaglandin analogs
|
|
WO1993012086A1
(fr)
|
1991-12-11 |
1993-06-24 |
Ss Pharmaceutical Co., Ltd. |
Derive d'arylamide
|
|
CA2090283A1
(en)
*
|
1992-02-28 |
1993-08-29 |
Nobuyuki Hamanaka |
Phenoxyacetic acid derivatives
|
|
ES2156120T3
(es)
*
|
1992-12-08 |
2001-06-16 |
Ss Pharmaceutical Co |
Derivados arilamidicos.
|
|
JPH06313995A
(ja)
*
|
1993-04-28 |
1994-11-08 |
Hodogaya Chem Co Ltd |
静電荷像現像用トナー
|
|
DE69411803T2
(de)
|
1993-04-30 |
1998-12-03 |
Kabushiki Kaisha Meidensha, Tokio/Tokyo |
Elektrode und Verfahren zur Herstellung eines Elektrodenmaterials
|
|
JPH07140725A
(ja)
|
1993-06-25 |
1995-06-02 |
Hodogaya Chem Co Ltd |
負帯電性トナー用摩擦帯電付与部材
|
|
JPH07233153A
(ja)
*
|
1994-02-18 |
1995-09-05 |
Dainippon Pharmaceut Co Ltd |
７位が置換された１−（２−ヒドロキシフェニル）−２（１ｈ）−キノキサリノン誘導体
|
|
BR9610207A
(pt)
|
1995-08-28 |
1999-02-02 |
American Home Prod |
Acidos fenóxi acéticos como inibidores da aldose redutase e agentes anti-hiperglicêmicos
|
|
FR2743366B1
(fr)
*
|
1996-01-10 |
1998-02-06 |
Rhone Poulenc Rorer Sa |
Derives de 5h,10h-imidazo(1,2-a)indeno(1,2-e)pyrazine-4-one, leur preparation, leurs intermediaires et les medicaments les contenant
|
|
RU2221781C2
(ru)
|
1996-07-22 |
2004-01-20 |
Монсанто Компани |
Тиолсульфоновые соединения в качестве ингибитора матриксной металлопротеазы и способы лечения
|
|
CA2219269A1
(en)
|
1996-10-29 |
1998-04-29 |
Novartis Ag |
Novel herbicides
|
|
FR2763588B1
(fr)
*
|
1997-05-23 |
1999-07-09 |
Cird Galderma |
Composes triaromatiques, compositions les contenant et utilisations
|
|
GB9714249D0
(en)
|
1997-07-08 |
1997-09-10 |
Angiogene Pharm Ltd |
Vascular damaging agents
|
|
CO4960662A1
(es)
*
|
1997-08-28 |
2000-09-25 |
Novartis Ag |
Ciertos acidos 5-alquil-2-arilaminofenilaceticos y sus derivados
|
|
US5942532A
(en)
|
1997-09-05 |
1999-08-24 |
Ortho Pharmaceutical Corporation |
2-substituted phenyl-benzimidazole antibacterial agents
|
|
ATE273279T1
(de)
|
1997-09-12 |
2004-08-15 |
Merck Frosst Canada Inc |
2,3,5-trisubstituierte pyridine als inhibitoren von cyclooxygenase-2
|
|
KR100340273B1
(ko)
*
|
1997-10-14 |
2002-06-14 |
야마모토 카즈모토 |
비페닐-5-알칸산 유도체 및 이의 용도
|
|
CA2322742A1
(en)
*
|
1998-03-13 |
1999-09-23 |
Merck Frosst Canada & Co./Merck Frosst Canada & Cie |
Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
|
|
CZ290693B6
(cs)
*
|
1998-06-19 |
2002-09-11 |
Vúfb, A. S. |
Deriváty hydroxyfenylmerkaptobenzoových a hydroxyfenylmerkaptoaryloctových kyselin s antileukotrienovou aktivitou
|
|
GB9900334D0
(en)
|
1999-01-07 |
1999-02-24 |
Angiogene Pharm Ltd |
Tricylic vascular damaging agents
|
|
GB9900752D0
(en)
|
1999-01-15 |
1999-03-03 |
Angiogene Pharm Ltd |
Benzimidazole vascular damaging agents
|
|
ATE303376T1
(de)
*
|
1999-06-03 |
2005-09-15 |
Nippon Suisan Kaisha Ltd |
Tricyclische kondensierte heterocyclische verbindungen, verfahren zu ihrer herstellung und ihre verwendung
|
|
US6884593B1
(en)
|
1999-08-23 |
2005-04-26 |
Bml, Inc. |
Method of identifying properties of substance with respect to human prostaglandin D2 receptors
|
|
US6417212B1
(en)
|
1999-08-27 |
2002-07-09 |
Eli Lilly & Company |
Modulators of peroxisome proliferator activated receptors
|
|
EP1259494A4
(en)
|
2000-02-18 |
2004-09-15 |
Merck & Co Inc |
ARYLOXYACETIC ACIDS FOR DIABETES AND LIPID DISORDERS
|
|
WO2003022814A1
(en)
|
2001-09-07 |
2003-03-20 |
Ono Pharmaceutical Co., Ltd. |
Indole derivatives
|
|
WO2001081312A2
(en)
|
2000-04-24 |
2001-11-01 |
Merck Frosst Canada & Co. |
Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
|
|
AU2001258628A1
(en)
|
2000-05-31 |
2001-12-11 |
Astrazeneca Ab |
Indole derivatives with vascular damaging activity
|
|
KR20030017569A
(ko)
*
|
2000-06-28 |
2003-03-03 |
테바 파마슈티컬 인더스트리즈 리미티드 |
카르베딜올
|
|
MXPA02012905A
(es)
|
2000-07-07 |
2004-07-30 |
Angiogene Pharm Ltd |
Derivados de colquinol como agentes de dano vascular..
|
|
US6878522B2
(en)
|
2000-07-07 |
2005-04-12 |
Baiyong Li |
Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2
|
|
BR0112225A
(pt)
|
2000-07-07 |
2003-05-06 |
Angiogene Pharm Ltd |
Composto, composição farmacêutica, uso de um composto, e, processo papa preparar um composto
|
|
US20040097555A1
(en)
*
|
2000-12-26 |
2004-05-20 |
Shinegori Ohkawa |
Concomitant drugs
|
|
CA2450167A1
(en)
*
|
2001-06-12 |
2002-12-19 |
Elan Pharmaceuticals, Inc. |
Macrocycles useful in the treatment of alzheimer's disease
|
|
EP1501826B1
(en)
|
2002-02-01 |
2006-09-27 |
F. Hoffman-la Roche AG |
Substituted indoles as alpha-1 agonists
|
|
SE0200411D0
(sv)
|
2002-02-05 |
2002-02-05 |
Astrazeneca Ab |
Novel use
|
|
WO2003068744A1
(en)
|
2002-02-18 |
2003-08-21 |
Ishihara Sangyo Kaisha, Ltd. |
Pyridine derivatives or salts thereof and cytokine production inhibitors containing the same
|
|
US7078421B2
(en)
*
|
2002-03-20 |
2006-07-18 |
Metabolex, Inc. |
Substituted phenylacetic acids
|
|
WO2003097042A1
(en)
|
2002-05-16 |
2003-11-27 |
Shionogi & Co., Ltd. |
Pgd2 receptor antagonist
|
|
WO2003097598A1
(en)
|
2002-05-16 |
2003-11-27 |
Shionogi & Co., Ltd. |
Compound exhibiting pgd 2 receptor antagonism
|
|
SE0201635D0
(sv)
|
2002-05-30 |
2002-05-30 |
Astrazeneca Ab |
Novel compounds
|
|
SE0202241D0
(sv)
|
2002-07-17 |
2002-07-17 |
Astrazeneca Ab |
Novel Compounds
|
|
PE20040844A1
(es)
*
|
2002-11-26 |
2004-12-30 |
Novartis Ag |
Acidos fenilaceticos y derivados como inhibidores de la cox-2
|
|
MXPA05006701A
(es)
|
2002-12-20 |
2006-03-30 |
Amgen Inc |
Moduladores de asma y de inflacion alergica.
|
|
CN1768040A
(zh)
|
2003-03-28 |
2006-05-03 |
伊莱利利公司 |
作为akt(蛋白激酶b)抑制剂的异喹啉－5－磺酸酰胺
|
|
SE0301010D0
(sv)
*
|
2003-04-07 |
2003-04-07 |
Astrazeneca Ab |
Novel compounds
|
|
SE0301009D0
(sv)
|
2003-04-07 |
2003-04-07 |
Astrazeneca Ab |
Novel compounds
|
|
DE60303238T2
(de)
|
2003-04-25 |
2006-09-14 |
Actimis Pharmaceuticals, Inc., La Jolla |
Pyrimidin-Essigsäure Derivate geeignet zur Behandlung von CRTH2-bedingten Krankheiten
|
|
SA04250253B1
(ar)
|
2003-08-21 |
2009-11-10 |
استرازينيكا ايه بي |
احماض فينوكسي اسيتيك مستبدلة باعتبارها مركبات صيدلانية لعلاج الامراض التنفسية مثل الربو ومرض الانسداد الرئوي المزمن
|
|
GB0324763D0
(en)
|
2003-10-23 |
2003-11-26 |
Oxagen Ltd |
Use of compounds in therapy
|
|
US7166738B2
(en)
*
|
2004-04-23 |
2007-01-23 |
Roche Palo Alto Llc |
Non-nucleoside reverse transcriptase inhibitors
|
|
GB0409921D0
(en)
|
2004-05-04 |
2004-06-09 |
Novartis Ag |
Organic compounds
|
|
EP2336113A1
(en)
|
2004-05-29 |
2011-06-22 |
7TM Pharma A/S |
CRTH2 Receptor Ligands for Medical Use
|
|
GB0415320D0
(en)
|
2004-07-08 |
2004-08-11 |
Astrazeneca Ab |
Novel compounds
|
|
GB0418830D0
(en)
*
|
2004-08-24 |
2004-09-22 |
Astrazeneca Ab |
Novel compounds
|
|
GB0422057D0
(en)
|
2004-10-05 |
2004-11-03 |
Astrazeneca Ab |
Novel compounds
|
|
UY29223A1
(es)
|
2004-11-23 |
2006-06-30 |
Astrazeneca Ab |
Ácidos fenoxiacéticos sustituidos, composiciones farmacéuticas que los contienen y procesos para su preparación
|
|
GB0510584D0
(en)
|
2005-05-24 |
2005-06-29 |
Novartis Ag |
Organic compounds
|
|
TW200745003A
(en)
|
2005-10-06 |
2007-12-16 |
Astrazeneca Ab |
Novel compounds
|
|
EP1937632A1
(en)
*
|
2005-10-06 |
2008-07-02 |
Astra Zeneca AB |
Novel compounds
|
|
US20080255150A1
(en)
*
|
2005-11-05 |
2008-10-16 |
Astrazeneca Ab |
Novel Compounds
|
|
ATE545637T1
(de)
|
2005-12-15 |
2012-03-15 |
Astrazeneca Ab |
Substituierte diphenylether, -amine, -sulfide und methane zur behandlung von atemwegserkrankungen
|
|
UA100983C2
(ru)
*
|
2007-07-05 |
2013-02-25 |
Астразенека Аб |
Бифенилоксипропановая кислота как модулятор crth2 и интермедиаты
|